CFF, Cebrim. “Sitagliptina: Riscos Superam benefícios”. Farmacoterapêutica 14, no. 05/06 (March 23, 2016): 6. Accessed September 1, 2024. https://revistas.cff.org.br/farmacoterapeutica/article/view/1436.